Pyrrolidine derivatives

Details for Australian Patent Application No. 2009222198 (hide)

Owner National Health Research Institutes

Inventors Hsu, Tsu; Jiaang, Weir-torn; Chao, Yusheng; Tsai, Ting-yueh

Agent Griffith Hack

Pub. Number AU-A-2009222198

PCT Pub. Number WO2009/111239

Priority 61/033,877 05.03.08 US

Filing date 25 February 2009

Wipo publication date 11 September 2009

International Classifications

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 207/02 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111239 Priority application(s): WO2009/111239

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009222199-Anti-amyloid beta activity of intravenous immunoglobulin (IVIG) in vitro

2009222194-Liquid extreme pressure additive